Related references
Note: Only part of the references are listed.Epidemiology of Hepatocellular Carcinoma
Kelly J. Lafaro et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Hepatocellular carcinoma epidemiology
Cristina Bosetti et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Hepatocellular carcinoma tumour markers: Current role and expectations
Nicole Rich et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Pathogenesis of hepatocellular carcinoma according to aetiology
Jean-Charles Nault
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go?
Hashem B. El-Serag et al.
HEPATOLOGY (2014)
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
Yujin Hoshida et al.
JOURNAL OF HEPATOLOGY (2014)
The Role of MicroRNAs in the Control of Innate Immune Response in Cancer
Simon Jasinski-Bergner et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Regulation of microRNA function in somatic stem cell proliferation and differentiation
Archana Shenoy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma
Priyanka Gupta et al.
VIROLOGY JOURNAL (2014)
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis
Mark J. Bolland et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
Andre J. Scheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Verena Koeberle et al.
EUROPEAN JOURNAL OF CANCER (2013)
Hepatitis B Virus mRNA-Mediated miR-122 Inhibition Upregulates PTTG1-Binding Protein, Which Promotes Hepatocellular Carcinoma Tumor Growth and Cell Invasion
Changfei Li et al.
JOURNAL OF VIROLOGY (2013)
MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells
Patricia A. Thibault et al.
VIROLOGY (2013)
Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure
Jeremy J. Walker et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/ß-catenin pathway
Jie Xu et al.
LIVER INTERNATIONAL (2012)
Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis
Oliver Waidmann et al.
PLOS ONE (2012)
Liver-specific microRNA-122 Biogenesis and function
Catherine L. Jopling
RNA BIOLOGY (2012)
Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
Peng Qi et al.
PLOS ONE (2011)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
Share Paper
